Latest KFF Health News Stories
KFF Health News' 'What the Health?': Cutting Medicaid Is Hard — Even for the GOP
Republicans on Capitol Hill are struggling to reach consensus on cutting the Medicaid program as they search for nearly a trillion dollars in savings over the next decade — as many observers predicted. Meanwhile, turmoil continues at the Department of Health and Human Services, with more controversial cuts and personnel moves, including the sudden nomination of Casey Means, an ally of Robert F. Kennedy Jr.’s, to become surgeon general. Anna Edney of Bloomberg News, Maya Goldman of Axios, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Lauren Sausser, who co-reported the latest “Bill of the Month” feature, about an unexpected bill for what seemed like preventive care.
California’s Primary Care Shortage Persists Despite Ambitious Moves To Close Gap
The state has in recent years embraced several initiatives recommended in an influential health care workforce report, including alternative payment arrangements for primary care doctors to earn more. Despite increasing residency programs, student debt forgiveness, and tuition-free medical school, California is unlikely to meet patient demand, observers say.
He Went in for a Colonoscopy. The Hospital Charged $19,000 for Two.
A man in Chicago with a troubling symptom underwent a common procedure. Then he wanted to know why the hospital charged nearly three times its own cost estimate.
¿Se puede confiar en una mamografía para identificar el riesgo de enfermedad cardíaca?
La enfermedad cardíaca es la principal causa de muerte en los Estados Unidos. Fue responsable de más de 300,000 —o aproximadamente 1 de cada 5— muertes de mujeres en 2021.
Can You Rely on Your Mammogram To Identify Heart Disease Risk?
Clinicians and researchers are searching for answers to whether an incidental finding on breast X-rays could improve the detection of cardiovascular disease risk among women.
If Lawsuit Ends Federal Mandates on Birth Control Coverage, States Will Have the Say
An ongoing lawsuit aims to set aside the Affordable Care Act’s requirements that insurers cover preventive care, such as contraception. If that happens, state reproductive health laws — varying across the country — would carry more weight, resuming the “wild West” dynamic from before Obamacare.
Ouch. That ‘Free’ Annual Checkup Might Cost You. Here’s Why.
The designers of the Affordable Care Act might have assumed that they spelled out with sufficient clarity that millions of Americans would no longer have to pay for certain types of preventive care. But they didn’t reckon with America’s ever-creative medical billing juggernaut.
Out for Blood? For Routine Lab Work, the Hospital Billed Her $2,400
Convenient as it may be, beware of getting your blood drawn at a hospital. The cost could be much higher than at an independent lab, and your insurance might not cover it all.
Mammograms at 40? Breast Cancer Screening Guidelines Spark Fresh Debate
There is no direct evidence that screening women in their 40s will save lives, yet modeling suggests expanding routine mammography to include them might avert 1.3 deaths per 1,000. Highlighting the risk of false positives, some specialists call for a more personalized approach.
¿Mamografías a los 40? Nueva pauta para la detección del cáncer de seno genera debate
Algunos médicos e investigadores que están interesados en un enfoque más individualizado para encontrar tumores problemáticos se muestran escépticos y plantean preguntas sobre los datos y el razonamiento detrás del cambio radical del Grupo de Trabajo de Servicios Preventivos de Estados Unidos
Journalists Explain Impact of Texas Judge’s ACA Decision and Cuts in Federal Food Benefits
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
No-Cost Preventive Services Are Now in Jeopardy. Here’s What You Need to Know.
A federal judge’s recent ruling on the Affordable Care Act is by no means the final word. Even parsing its impact is complicated. Here are key issues to watch as the case works its way through the legal system.
La decisión podría afectar los exámenes de detección sin copago y servicios preventivos similares que la mayoría de los estadounidenses con seguro tienen como parte de sus planes de salud.
Judge’s Decision Would Make Some No-Cost Cancer Screenings a Thing of the Past
A U.S. District Court ruling overturned the section of the Affordable Care Act that makes preventive health services — from colonoscopies to diabetes screenings and more — available at no cost to consumers.
California’s Massive Medicaid Program Works for Some, but Fails Many Others
Medi-Cal serves more than one-third of the state’s population — offering a dizzying range of care to a diverse population. In the new “Faces of Medi-Cal” series, California Healthline will assess the program’s strengths and weaknesses through the lives and experiences of its enrollees.
¿Comprando seguro de salud de ACA? Aquí, lo nuevo de este año
Comprar ahora significa tener cobertura vigente a partir del 1o de enero de 2023. Aunque gran parte de los planes permanecen iguales año tras año , hay algunos cambios que los consumidores deben tener en cuenta.
Shopping for ACA Health Insurance? Here’s What’s New This Year
Consumers may find relief in some key changes made by Congress and the Biden administration, although other issues remain unsettled.
Journalists Dig In on the Fiscal Health of the Nation and Hospital Closures in Rural Missouri
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
La última década ha sido testigo de una rápida expansión de las pruebas genéticas. Pero, ¿cuál es su real relevancia clínica?
Genetic Tests Create Treatment Opportunities and Confusion for Breast Cancer Patients
Doctors are divided on whether blanket testing of breast cancer patients is warranted, since scientists and physicians are sometimes unsure about how to interpret the results.
